PFE Q1 FY2026 Sankey: $14.5B revenue, +5.4% YoY — QuarterCharts

Company logos shown on QuarterCharts are trademarks of their respective owners and are used solely for identification of the company whose data is displayed. Their use does not imply endorsement, sponsorship, or affiliation with the trademark owners. Full trademarks policy.

Data sourced from SEC EDGAR, and Finnhub. QuarterCharts is not affiliated with SEC or any issuer.

QuarterSankey

Pfizer Inc.PFEPFEIncome Sankey

Charts Sankey Profile Earnings Watchlist

Income Statement Balance Sheet Cash Flow

ComparingFY2026 (Q1+Q2+Q3+Q4) vs FY2025 (Q1+Q2+Q3+Q4)

Click a Metric or Sankey Node to View Historical Trends

Show Source Data (Audit Panel)

Reconciled values per the quarterly mode pipeline. Compare against SEC EDGAR filings.
Line item	FY2026 (Q1+Q2+Q3+Q4)	FY2025 (Q1+Q2+Q3+Q4)
Revenue	$14.45B	$62.58B
COGS	$3.55B	$16.07B
Gross Profit	$10.9B	$46.51B
R&D	$2.49B	$10.44B
SG&A	$2.96B	$13.79B
D&A	$1.61B	$6.59B
Other OpEx	$861M

QuarterCharts · SEC EDGAR data · PFE · Comparing FY2026 (Q1+Q2+Q3+Q4) vs FY2025 (Q1+Q2+Q3+Q4)

Trust & Legal

Quarter Comparison